The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19

The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19

BackgroundThe therapeutic options for patients with coronavirus disease (COVID-19) are limited. Mesenchymal stem cells (MSCs) have immunomodulatory and regenerative properties that may inhibit excessive inflammatory responses, promote recovery from COVID-19-induced lung injury, and potentially serve...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiqi Yao, Boran Li, Yingan Jiang, Qiaoyu Yuan, Wenjie Wu, Ruizhen Hou, Qi Qi, Haibo Dong, Yun Zhang, Yu Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
COVID-19
human umbilical cord-derived mesenchymal stem cells
inflammation
lung injury
therapeutic options
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1594373/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1594373/full

Similar Items